With the sequencing of the human genome in 2003, genetics has become one of the most exciting fields in medicine, and research is expanding exponentially. Interventions and therapies customized to individual patients will be among the most striking outcomes.
This groundbreaking initiative expands the science of targeted medicine. The Consortium is helping to innovate and accelerate the new era of precision medicine by fostering pre-competitive alliances of the public and private sectors. Composed of several disease-focused efforts, the consortium’s central aim is to identify, develop, and qualify measureable indicators of biological and pathological processes – biomarkers – to advance specific applications for diagnosing disease, predicting therapeutic response, and improving clinical practice using new and existing technologies.
Funded by the Bill & Melinda Gates Foundation, Grand Challenges in Global Health encompasses 43 project across 33 countries, working toward scientific breakthroughs to prevent, treat and cure diseases that kill millions each year.
Poor nutrition is linked to more than half of all child deaths worldwide. This initiative, funded by the Bill & Melinda Gates Foundation, draws together an international group of scientific investigators to study the inter-relationship between enteric infections and malnutrition to reduce its devastating effects.
First described more than 100 years ago, Alzheimer’s disease (AD) has no cure or lasting, effective treatment. Currently, more than 5 million people in the United States suffer from it and its incidence is projected to increase dramatically over the next 20 years.
In 2007, the Genetic Association Information Network (GAIN) completed an ambitious program to genotype existing research studies in six major common diseases, and combine the results with clinical data to create a significant new resource for genetic researchers.